R. Bringiotti

Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry

G. Logroscino, F. Panza, D. Seripa, 2017, Expert review of proteomics.

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites.

A. Gasbarrini, A. Andrealli, P. Angeli, 2020, Journal of hepatology.

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.

A. Gasbarrini, M. Pompili, U. Visco-Comandini, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation.

A. Di Leo, E. Ierardi, R. Bringiotti, 2015, Journal of gastrointestinal and liver diseases : JGLD.

Prevalence of Zinc Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

G. Giannelli, R. Sardone, R. Bringiotti, 2022, Nutrients.

T-48 Efficacy and safety of intravenous silibinin in patients with HCV recurrence on the graft after liver transplantation (LT): a prospective, randomized, double-blind, placebo-controlled pilot study

R. Bringiotti, M. D'Amato, A. Castellaneta, 2013 .

Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?

A. Di Leo, E. Ierardi, R. Bringiotti, 2014, World journal of gastrointestinal pathophysiology.

Diet, Probiotics and Physical Activity: The Right Allies for a Healthy Microbiota

A. Paradiso, R. Bringiotti, G. De Palma, 2021, AntiCancer Research.

Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study.

A. Alibrandi, F. Manguso, V. Annese, 2019, European journal of gastroenterology & hepatology.

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

A. Gasbarrini, A. Andrealli, P. Angeli, 2018, The Lancet.

Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical outcome

A. Di Leo, R. Bringiotti, P. Burra, 2011 .

Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: a randomized clinical trial

A. Di Leo, R. Bringiotti, M. D'Amato, 2014, Transplant international : official journal of the European Society for Organ Transplantation.